GLOBAL COALITION FOR ADAPTIVE RESEARCH INC

As filed

Subsection

03

NTEE code

H48

Classification

1000

Street

1300 S ELISEO DR STE 103

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2025

• GBM AGILE (GLIOBLASTOMA ADAPTIVE GLOBAL INNOVATIVE LEARNING ENVIRONMENT) IS UNIQUELY DESIGNED AS A LONG-STANDING PLATFORM WITH THE ABILITY TO TEST MULTIPLE THERAPIES AT THE SAME TIME AGAINST A COMMON CONTROL (OR STANDARD OF CARE). THE PURPOSE IS TO EVALUATE MULTIPLE INVESTIGATIONAL TREATMENTS FOR EITHER NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA TO DETERMINE IF ANY OF THESE STUDY TREATMENT(S) IMPROVE OVERALL SURVIVAL AS COMPARED TO STANDARD TREATMENTS.

  Expenses $27,443,955 · Grants $19,670 · Revenue $26,667,789

• OTHER ONGOING PROGRAMS OR PROGRAMS IN DEVELOPMENT GCAR SERVES AS THE REGULATORY SPONSORSHIP OF THE MILITARY AND VETERANS PTSD ADAPTIVE PLATFORM CLINICAL TRIAL (M-PACT). PARTNERING WITH OPERATIONAL MEDICAL SYSTEMS, PART OF THE DEFENSE HEALTH AGENCY, GCAR IS CONDUCTING AN ADAPTIVE PLATFORM TRIAL AT IS EVALUATING MULTIPLE PHARMACOTHERAPEUTIC INTERVENTIONS FOR THE TREATMENT OF PTSD FOR ACTIVE-DUTY SERVICE MEMBERS AND VETERANS WITH PTSD AT MULTIPLE CLINICAL SITES IN THE US. THIS PROGRAM IS SUPPORTED BY A PROJECT TEAM THAT ALSO INCLUDES REPRESENTATIVES FROM THE U.S. AIR FORCE, ARMY, NAVY, AND SPECIAL OPERATIONS COMMAND. GCAR IS COMMITTED TO DESIGNING, LAUNCHING, AND OVERSEEING SEVERAL INITIATIVES CURRENTLY IN DEVELOPMENT TO RAPIDLY AND EFFICIENTLY EVALUATE NEW TREATMENTS FOR RARE AND LETHAL DISEASES, INCLUDING PANCREATIC CANCER, BILIARY TRACT CANCER, HIGH AND LOW GRADE SEROUS OVARIAN CANCER, AND NEUROFIBROMATOSIS. GCAR ALSO SUPPORTS EDUCATION, OUTREACH, AND CLINICAL COMMUNITY ENGAGEMENT TO ADDRESS THESE URGENT UNMET NEEDS.

  Expenses $2,463,891 · Revenue $2,867,102

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2025

  Revenue

  $32,444,163

  Expenses

  $32,607,809

  Contributions

  $1,028,577

  Grants paid

  $19,670

• 2024

  Revenue

  $27,688,488

  Expenses

  $30,895,157

  Contributions

  $1,668,304

  Grants paid

  $16,019

• 2023

  Revenue

  $28,779,160

  Expenses

  $29,710,627

  Contributions

  $3,081,228

  Grants paid

  $1,158,000

• 2022

  Revenue

  $35,373,148

  Expenses

  $24,083,323

  Contributions

  $543,271

  Grants paid

  $0

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $38,719,697

  Expenses

  $19,203,165

  Assets (EOY)

  $40,740,875

• 2020 · 990

  Revenue

  $15,863,066

  Expenses

  $10,452,245

  Assets (EOY)

  $28,309,589

• 2019 · 990

  Revenue

  $11,915,160

  Expenses

  $5,226,911

  Assets (EOY)

  $7,395,124

• 2018 · 990

  Revenue

  $2,525,750

  Expenses

  $2,468,396

  Assets (EOY)

  $109,128

• 2017 · 990-EZ

  Revenue

  — not reported

  Expenses

  $105,881

  Assets (EOY)

  $44,119

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.

Grants made

• NATIONAL FOUNDATION FOR CANCER RESEARCH

  $500,000

  2023 · CLINICAL TRIAL SUPPORT

• AIM-HI ACCELERATOR FUND INC

  $500,000

  2023 · CLINICAL TRIAL SUPPORT

• CHOLANGIOCARCINOMA FOUNDATION

  $150,000

  2023 · CLINICAL TRIAL SUPPORT

• NATIONAL BRAIN TUMOR SOCIETY

  $10,000

  2024 · GBM AWARENESS DAY AND WALK SPONSORSHIP

• NATIONAL BRAIN TUMOR SOCIETY

  $10,000

  2025 · GBM AWARENESS DAY AND WALK SPONSORSHIP

Where these grants went next →

Grants received

• OVARIAN CANCER RESEARCH FUND INC

  $500,000

  2023 · RESEARCH GRANT

• UNIVERSITY OF PITTSBURGH

  $320,401

  2022 · RESEARCH- SUBCONTRACT

• UNIVERSITY OF PITTSBURGH

  $146,501

  2023 · RESEARCH- SUBCONTRACT

Related organizations

From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.

Other IRS files